Shabtai M, Ben-Haim M, Muntz Y, Vered I, Rosin D, Kuriansky J, Zmora O, Olchovski D, Ayalon A, Zwas S T
Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Israel.
Surg Endosc. 2003 May;17(5):688-91. doi: 10.1007/s00464-002-9198-7. Epub 2003 Mar 7.
The advent of highly accurate parathyroid imaging and the ever-increasing trend towards minimally invasive procedures have changed considerably the surgical approach to the patient with primary hyperparathyroidism (PHPT) caused by a single parathyroid adenoma. This study analyzes the short- and longer-term results of 140 patients who underwent minimally invasive, radio-guided parathyroidectomy.
Demographic, clinical, and pre-operative imaging data, operative findings, and short- and long-term results of 140 consecutive patients operated within a 20 months period (8/1999-4/2002), were prospectively entered into a database. Immediate pre-operative sestamibi scintigraphy with skin marking of focal adenoma uptake were followed by intraoperative hand-held gamma probe for the removal of the parathyroid adenoma by unilateral minimal access surgery. Preoperative and surgical data were analyzed and correlated to outcomes, measured by success or failure to cure PHPT, associated morbidity and mortality, predictive value of localizing studies, and postoperative laboratory results in the immediate as well as long-term period.
140 patients, mean age: 55.1 +/- 14.1 years (range 19-88 years), female to male ratio 94:46 with PHPT proven by concomitantly elevated serum calcium and parathormone (PTH) levels, with a single adenoma identified by sestamibi single photon emission tomography (SPECT) scintigraphy and high-resolution sonography, underwent minimally invasive, radio-guided parathyroidectomy. Mean serum levels of preoperative calcium, phosphorus, and PTH were 11.6 +/- 0.8 mg/dL (range 9.1-14), 3.0 +/- 0.3 mg/dL, and 147.1 +/- 94.3 pg/mL (range 68-784), respectively. Overall, in 3 out of 140 patients (2.1%), focused, minimally invasive surgery failed to identify and remove the adenoma. Positive predictive value when both localizing modalities concurred was 99.2%. Positive predictive value of SPECT scan alone was 97.2%. Overall success rate was 97.8% (137/140). 24 hours postoperative mean serum calcium was 9.2 +/- 0.8 mg/dL and at 6 months mean serum calcium, phosphorus, and PTH were 9.4 +/- 1.06 mg/dL, 3.2 +/- 0.8 mg/dL, and 32.1 +/- 11.9 pg/mL, respectively (p = 0.0001). There was no mortality. In 2 patients (1.4%) there was transient vocal cord paresis and there were 8 instances of clinically significant hypocalcemia. In 3 cases (2.1%), a second adenoma manifested itself 9-14 months following surgery and was removed by minimal access procedure.
Minimally invasive, radio-guided focused parathyroidectomy for a single adenoma is safe and effective in curing hyperparathyroidism with a 97% success rate. A second adenoma occurring in less than 3% may be successfully treated with a second minimal access operation. The combined positive predictive value of concurring sestamibi SPECT scintigraphy and sonography of 99.2% may increase success rate, and thus implementing this technique in patients with concurring sonography and scintigraphy may be advocated.
高精度甲状旁腺成像技术的出现以及微创外科手术日益增长的趋势,极大地改变了因单发甲状旁腺腺瘤导致原发性甲状旁腺功能亢进症(PHPT)患者的手术方式。本研究分析了140例行微创放射性引导甲状旁腺切除术患者的短期和长期结果。
前瞻性地将140例在20个月期间(1999年8月至2002年4月)接受手术患者的人口统计学、临床和术前影像学数据、手术发现以及短期和长期结果录入数据库。术前即刻进行锝-99m甲氧基异丁基异腈(sestamibi)闪烁扫描并标记局灶性腺瘤摄取部位,随后术中使用手持式γ探头通过单侧微创入路手术切除甲状旁腺腺瘤。分析术前和手术数据,并将其与治疗结果相关联,治疗结果通过治愈PHPT的成功或失败、相关发病率和死亡率、定位研究的预测价值以及术后即刻和长期的实验室检查结果来衡量。
140例患者,平均年龄:55.1±14.1岁(范围19至88岁),男女比例为94:46,血清钙和甲状旁腺激素(PTH)水平同时升高证实患有PHPT,通过sestamibi单光子发射断层扫描(SPECT)闪烁扫描和高分辨率超声检查确定为单发腺瘤,接受了微创放射性引导甲状旁腺切除术。术前血清钙、磷和PTH的平均水平分别为11.6±0.8mg/dL(范围9.1至14)、3.0±0.3mg/dL和147.1±94.3pg/mL(范围68至784)。总体而言,140例患者中有3例(2.1%),聚焦的微创手术未能识别并切除腺瘤。两种定位方法一致时的阳性预测值为99.2%。单独SPECT扫描的阳性预测值为97.2%。总体成功率为9